114 related articles for article (PubMed ID: 21091043)
21. Development of yeast reporter assay for screening specific ligands of retinoic acid and retinoid X receptor subtypes.
Shiizaki K; Yoshikawa T; Takada E; Hirose S; Ito-Harashima S; Kawanishi M; Yagi T
J Pharmacol Toxicol Methods; 2014; 69(3):245-52. PubMed ID: 24530888
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional separation of retinoic acid receptor neutral antagonists and inverse agonists.
Klein ES; Pino ME; Johnson AT; Davies PJ; Nagpal S; Thacher SM; Krasinski G; Chandraratna RA
J Biol Chem; 1996 Sep; 271(37):22692-6. PubMed ID: 8798442
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for isotype selectivity of the human retinoic acid nuclear receptor.
Klaholz BP; Mitschler A; Moras D
J Mol Biol; 2000 Sep; 302(1):155-70. PubMed ID: 10964567
[TBL] [Abstract][Full Text] [Related]
24. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
25. Retinoic acid receptor beta,gamma-selective ligands: synthesis and biological activity of 6-substituted 2-naphthoic acid retinoids.
Yu KL; Spinazze P; Ostrowski J; Currier SJ; Pack EJ; Hammer L; Roalsvig T; Honeyman JA; Tortolani DR; Reczek PR; Mansuri MM; Starrett JE
J Med Chem; 1996 Jun; 39(12):2411-21. PubMed ID: 8691435
[TBL] [Abstract][Full Text] [Related]
26. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
Altucci L; Rossin A; Hirsch O; Nebbioso A; Vitoux D; Wilhelm E; Guidez F; De Simone M; Schiavone EM; Grimwade D; Zelent A; de Thé H; Gronemeyer H
Cancer Res; 2005 Oct; 65(19):8754-65. PubMed ID: 16204045
[TBL] [Abstract][Full Text] [Related]
27. Molecular and metabolic retinoid pathways in the human ocular surface.
Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V
Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666
[TBL] [Abstract][Full Text] [Related]
28. Receptor-selective retinoid agonists and teratogenic activity.
Willhite CC; Dawson MI; Reichert U
Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
[TBL] [Abstract][Full Text] [Related]
29. Synthetic retinoids: structure-activity relationships.
Barnard JH; Collings JC; Whiting A; Przyborski SA; Marder TB
Chemistry; 2009 Nov; 15(43):11430-42. PubMed ID: 19821467
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.
Marchwicka A; Cunningham A; Marcinkowska E; Brown G
Expert Opin Ther Pat; 2016 Aug; 26(8):957-71. PubMed ID: 27336223
[TBL] [Abstract][Full Text] [Related]
31. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
Uray IP; Dmitrovsky E; Brown PH
Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
[TBL] [Abstract][Full Text] [Related]
32. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
[TBL] [Abstract][Full Text] [Related]
33. Initiation of retinoid signaling in primitive streak mouse embryos: spatiotemporal expression patterns of receptors and metabolic enzymes for ligand synthesis.
Ang HL; Duester G
Dev Dyn; 1997 Apr; 208(4):536-43. PubMed ID: 9097025
[TBL] [Abstract][Full Text] [Related]
34. Involvement of retinoic acid receptor alpha in the stimulation of tissue-type plasminogen-activator gene expression in human endothelial cells.
Kooistra T; Lansink M; Arts J; Sitter T; Toet K
Eur J Biochem; 1995 Sep; 232(2):425-32. PubMed ID: 7556191
[TBL] [Abstract][Full Text] [Related]
35. The retinoid receptors.
Pemrick SM; Lucas DA; Grippo JF
Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
[TBL] [Abstract][Full Text] [Related]
36. Keratins 2 and 4/13 in reconstituted human skin are reciprocally regulated by retinoids binding to nuclear receptor RARalpha.
Virtanen M; Sirsjö A; Vahlquist A; Törmä H
Exp Dermatol; 2010 Jul; 19(7):674-81. PubMed ID: 20456496
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
Dawson MI; Hobbs PD; Peterson VJ; Leid M; Lange CW; Feng KC; Chen Gq ; Gu J; Li H; Kolluri SK; Zhang Xk ; Zhang Y; Fontana JA
Cancer Res; 2001 Jun; 61(12):4723-30. PubMed ID: 11406543
[TBL] [Abstract][Full Text] [Related]
38. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
39. Differential action on coregulator interaction defines inverse retinoid agonists and neutral antagonists.
Germain P; Gaudon C; Pogenberg V; Sanglier S; Van Dorsselaer A; Royer CA; Lazar MA; Bourguet W; Gronemeyer H
Chem Biol; 2009 May; 16(5):479-89. PubMed ID: 19477412
[TBL] [Abstract][Full Text] [Related]
40. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
